Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
GenomeMiner (formerly Tupac.Bio)
Onna, Japan
A
1-10 Employees
2015
Key takeaway
GenomeMiner focuses on leveraging bioinformatics to enhance the sustainable production of natural products and the discovery of novel compounds, which aligns with the principles of synthetic biology. Their development of biofungicides and bioinsecticides showcases their commitment to innovative, DNA-driven solutions for a sustainable future.
Reference
Core business
home
GeneFrontier Japan
Sakai, Japan
A
- Employees
2010
Key takeaway
The company specializes in protein engineering and biologics, utilizing phage display technology to develop novel biopharmaceutical candidates, including high-performance antibodies and cyclic peptides.
Reference
Product
Drug Discovery | 日本語版
SBX Corporation
Tokyo, Japan
A
11-50 Employees
2011
Key takeaway
The Systems Biology Institute (SBI) and its affiliated entities, including SBX BioSciences, are dedicated to advancing systems biology and its applications in drug discovery and personalized healthcare. Through the integration of AI and computational systems biology, they aim to provide innovative solutions that address critical challenges in these fields.
Reference
Core business
SBX Corporation
AI R&D: Deep learning, Machine learning, Automation, Text mining. Development, customization and maintenance of software platforms for drug discovery and life science research.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Molcure
Tokyo, Japan
A
11-50 Employees
2013
Key takeaway
The company utilizes over 1 billion proprietary biopharmaceutical data and advanced AI technology to identify valuable antibodies and peptides, which is integral to the field of synthetic biology. Their approach includes directed evolution experiments and machine learning models to predict essential biopharmaceutical properties, enhancing the drug discovery process.
Reference
Core business
Molcure Inc. | Accelerating drug discovery
AceRNA
Kyoto, Japan
A
1-10 Employees
2018
Key takeaway
aceRNA is a biotech startup dedicated to creating innovative genetic therapies, particularly through the use of RNA Switches. Their focus on developing targeted treatments aligns with the principles of synthetic biology, aiming to address diseases while reducing patient burden.
Reference
Core business
Company - aceRNA
aceRNA
ReproCELL
Yokohama, Japan
A
51-100 Employees
2003
Key takeaway
REPROCELL specializes in translational research, offering a wide range of products and services that support stem cell research and the development of regenerative medicine therapies. Their expertise in induced pluripotent stem cells (iPSCs) and 3D bioengineered tissues positions them as key players in advancing synthetic biology applications.
Reference
Product
Products: ABLE® Biott® Bioreactor Systems
Purchase the ABLE® Biott® Bioreactor System from the human tissue and iPSC experts. Request a quote for delivery to the USA or Europe.
Beyond Next Ventures
Tokyo, Japan
A
1-10 Employees
2014
Key takeaway
The company, Beyond Next Ventures, is dedicated to supporting researchers and entrepreneurs in deep tech fields, including synthetic biology. They provide resources such as business planning, financial assistance, and access to incubation facilities, which are essential for the commercialization of innovative scientific advancements.
Reference
Product
Drug discovery / Biotech | Beyond Next Ventures
001
ThinkCyte
Tokyo, Japan
A
11-50 Employees
2016
Key takeaway
The company is at the forefront of advancing biology and medicine through innovative therapies and diagnostics. They utilize a novel ultrafast imaging technique combined with artificial intelligence for high-throughput characterization and sorting of cells, which is highly relevant to the field of synthetic biology.
Reference
Product
PLATFORMS Archive - ThinkCyte
Nature Architects
Tokyo, Japan
A
1-10 Employees
2017
Key takeaway
Nature Architects utilizes metamaterials and compliant mechanisms to revolutionize product design through their innovative DFM (Direct Functional Modeling) algorithm, enabling the creation of advanced functionalities that traditional manufacturing methods cannot achieve. This approach allows for the integration of new features, such as vibration absorption, into product components, fostering collaboration with clients across various industries for cutting-edge product development.
Reference
Product
TECHNOLOGIES | Nature Architects inc.
Optieum Biotechnologies
Matsuyama, Japan
A
1-10 Employees
2020
Key takeaway
Optieum Biotechnologies Inc. is involved in innovative technologies, which may include aspects relevant to synthetic biology.
Reference
Core business
OPTIEUM BIOTECHNOLOGIES
Technologies which have been searched by others and may be interesting for you:
When exploring the Synthetic Biology industry in Japan, several key considerations emerge. Regulatory frameworks in Japan are stringent, requiring companies to navigate complex biosafety and environmental laws. Understanding these regulations is crucial for compliance and successful market entry. The country is known for its robust research infrastructure, providing opportunities for innovation and collaboration with leading universities and institutions. However, challenges persist, such as limited public understanding and acceptance of synthetic biology applications, which can impact market growth. Environmental concerns are also significant, particularly regarding the sustainable use of biological resources and the potential ecological impact of synthetic organisms. Companies must address these issues proactively to gain public trust and ensure long-term viability. The competitive landscape features both established corporations and startups, fostering a dynamic environment for technological advancements. Furthermore, Japan's position as a leader in biotechnology enhances its global market relevance, making it an attractive destination for investment. Overall, individuals interested in this field should focus on understanding the regulatory environment, addressing public perception, leveraging research collaborations, and recognizing the importance of sustainability to navigate the complexities of the Synthetic Biology industry in Japan effectively.
Some interesting numbers and facts about your company results for Synthetic Biology
| Country with most fitting companies | Japan |
| Amount of fitting manufacturers | 32 |
| Amount of suitable service providers | 14 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2003 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Synthetic Biology
What are related technologies to Synthetic Biology?
Based on our calculations related technologies to Synthetic Biology are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Synthetic Biology?
The most represented industries which are working in Synthetic Biology are Other, Biotechnology, IT, Software and Services, Chemicals, Research
How does ensun find these Synthetic Biology Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.